Composition and Antigenic Activity of the Oligosaccharide Moiety of Haemophilus Influenzae Type B Lipooligosaccharide

Overview

Journal Infect Immun

Publisher American Society for Microbiology

Specialty Allergy & Immunology

Date 1985 May 1

PMID 3872843

Citations 20

Authors

T J Inzana

W E Seifert Jr

R P Williams

Affiliations

Soon will be listed here.

Abstract

The oligosaccharide moiety of the lipooligosaccharide of Haemophilus influenzae type b strain Eag was isolated from the lipid component by mild acid hydrolysis and purified by gel filtration. Fast atom bombardment-mass spectrometry indicated that the lipid-free oligosaccharide had a basic molecular weight of 1,768; polysaccharides comparable to high-molecular-weight O side chains were not found. Glucose, galactose, galactosamine, heptose, 3-deoxy-D-manno-2-octulosonic acid (KDO), ethanolamine, and phosphate were identified in the lipid-free oligosaccharide by colorimetric assays, gas chromatography-mass spectrometry, or an amino acid analyzer. The presence of KDO was not clearly established by a thiobarbituric acid assay or by growth inhibition by a diazaborine derivative thought to block KDO synthesis. However, the semicarbizide assay and gas chromatography-mass spectrometry confirmed the presence of KDO. Lectin precipitation by Eag lipooligosaccharide in gels indicated that beta-D-galactose was present and that some of this monosaccharide was a terminal, nonreducing residue linked to N-acetyl-D-galactosamine. The lipid-free oligosaccharide was antigenic and completely inhibited lipooligosaccharide antibody (predominantly immunoglobulin G [IgG] and IgM) in an enzyme-linked immunosorbent assay, whereas the solubilized lipid A moiety did not. H. influenzae type b lipid-free oligosaccharide differed from core oligosaccharide of Salmonella lipooligosaccharide by the presence of galactosamine and a smaller percentage of heptose and KDO.

Citing Articles

A mutation in the Neisseria gonorrhoeae rfaD homolog results in altered lipooligosaccharide expression.

Drazek E, Stein D, Deal C J Bacteriol. 1995; 177(9):2321-7.

PMID: 7730260 PMC: 176887. DOI: 10.1128/jb.177.9.2321-2327.1995.

Demonstration of lipopolysaccharide with O-polysaccharide chains among different heat-stable serotypes of Campylobacter jejuni by silver staining of polyacrylamide gels.

Blake Jr D, Russell R Infect Immun. 1993; 61(12):5384-7.

PMID: 7693600 PMC: 281326. DOI: 10.1128/iai.61.12.5384-5387.1993.

Isolation, purification, and partial characterization of a lipopolysaccharide from Haemophilus pleuropneumoniae.

Maudsley J, Kadis S, Mayberry W Infect Immun. 1986; 51(2):501-6.

PMID: 3943899 PMC: 262364. DOI: 10.1128/iai.51.2.501-506.1986.

Antigenic diversity of lipooligosaccharides of nontypable Haemophilus influenzae.

Campagnari A, Gupta M, Dudas K, Murphy T, Apicella M Infect Immun. 1987; 55(4):882-7.

PMID: 3549563 PMC: 260433. DOI: 10.1128/iai.55.4.882-887.1987.

Identification of phosphorylated 3-deoxy-manno-octulosonic acid as a component of Haemophilus influenzae lipopolysaccharide.

Zamze S, Ferguson M, Moxon E, Dwek R, Rademacher T Biochem J. 1987; 245(2):583-7.

PMID: 3499145 PMC: 1148161. DOI: 10.1042/bj2450583.

References

Allen P, Connelly M, Apicella M . Interaction of lectins with Neisseria gonorrhoeae. Can J Microbiol. 1980; 26(4):468-74. DOI: 10.1139/m80-078. View

Marks M, Ziegler E, Douglas H, Corbeil L, BRAUDE A . Induction of immunity against lethal Haemophilus influenzae type b infection by Escherichia coli core lipopolysaccharide. J Clin Invest. 1982; 69(4):742-9. PMC: 370127. DOI: 10.1172/jci110512. View

Johnson K, Perry M . Improved techniques for the preparation of bacterial lipopolysaccharides. Can J Microbiol. 1976; 22(1):29-34. DOI: 10.1139/m76-004. View

Strittmatter W, Weckesser J, Salimath P, Galanos C . Nontoxic lipopolysaccharide from Rhodopseudomonas sphaeroides ATCC 17023. J Bacteriol. 1983; 155(1):153-8. PMC: 217664. DOI: 10.1128/jb.155.1.153-158.1983. View

Zoon K, SCOCCA J . Constitution of the cell envelope of Haemophilus influenzae in relation to competence for genetic transformation. J Bacteriol. 1975; 123(2):666-77. PMC: 235774. DOI: 10.1128/jb.123.2.666-677.1975. View

Bjornson A, Bjornson H . Activation of complement by opportunist pathogens and chemotypes of Salmonella minnesota. Infect Immun. 1977; 16(3):748-53. PMC: 421025. DOI: 10.1128/iai.16.3.748-753.1977. View

Anderson P, JOHNSTON Jr R, Smith D . Human serum activities against Hemophilus influenzae, type b. J Clin Invest. 1972; 51(1):31-8. PMC: 332925. DOI: 10.1172/JCI106793. View

Raichvarg D, Brossard C, Agneray J . Chemical composition and biological activities of a phenol-water extract from Haemophilus influenzae type a. Infect Immun. 1979; 26(2):415-21. PMC: 414630. DOI: 10.1128/iai.26.2.415-421.1979. View

Munson Jr R, Shenep J, Barenkamp S, Granoff D . Purification and comparison of outer membrane protein P2 from Haemophilus influenzae type b isolates. J Clin Invest. 1983; 72(2):677-84. PMC: 1129227. DOI: 10.1172/JCI111017. View

10.

Goldstein I, Hayes C . The lectins: carbohydrate-binding proteins of plants and animals. Adv Carbohydr Chem Biochem. 1978; 35:127-340. DOI: 10.1016/s0065-2318(08)60220-6. View

11.

KARKHANIS Y, Zeltner J, Jackson J, Carlo D . A new and improved microassay to determine 2-keto-3-deoxyoctonate in lipopolysaccharide of Gram-negative bacteria. Anal Biochem. 1978; 85(2):595-601. DOI: 10.1016/0003-2697(78)90260-9. View

12.

OReilly R, Anderson P, INGRAM D, Peter G, Smith D . Circulating polyribophosphate in Hemophilus influenzae, type b meningitis. Correlation with clinical course and antibody response. J Clin Invest. 1975; 56(4):1012-22. PMC: 301957. DOI: 10.1172/JCI108148. View

13.

Banoub J, Shaw D, Michon F . Hydrolytic release, and identification by g.l.c.-m.s., of 3-deoxy-D-manno-2-octulosonic acid in the lipopolysaccharides isolated from bacteria of the Vibrionaceae. Carbohydr Res. 1983; 123(1):117-22. DOI: 10.1016/0008-6215(83)88386-4. View

14.

Morrison D, Kline L . Activation of the classical and properdin pathways of complement by bacterial lipopolysaccharides (LPS). J Immunol. 1977; 118(1):362-8. View

15.

Wright B, Rebers P . Procedure for determining heptose and hexose in lipopolysaccharides. Modification of the cysteine-sulfuric acid method. Anal Biochem. 1972; 49(2):307-19. DOI: 10.1016/0003-2697(72)90433-2. View

16.

Zwahlen A, Winkelstein J, Moxon E . Surface determinants of Haemophilus influenzae pathogenicity: comparative virulence of capsular transformants in normal and complement-depleted rats. J Infect Dis. 1983; 148(3):385-94. DOI: 10.1093/infdis/148.3.385. View

17.

JANN B, Jann K . Degradation studies on the lipopolysaccharide from E. coli 071:K?:H12. Separation and investigation of O-specific and core polysaccharides. FEBS Lett. 1968; 1(5):311-314. DOI: 10.1016/0014-5793(68)80141-3. View

18.

Costerton J, Ingram J, Cheng K . Structure and function of the cell envelope of gram-negative bacteria. Bacteriol Rev. 1974; 38(1):87-110. PMC: 413842. DOI: 10.1128/br.38.1.87-110.1974. View

19.

Inzana T . Electrophoretic heterogeneity and interstrain variation of the lipopolysaccharide of Haemophilus influenzae. J Infect Dis. 1983; 148(3):492-9. DOI: 10.1093/infdis/148.3.492. View

20.

Shenep J, Munson Jr R, Granoff D . Human antibody responses to lipopolysaccharide after meningitis due to Haemophilus influenzae type b. J Infect Dis. 1982; 145(2):181-90. DOI: 10.1093/infdis/145.2.181. View